The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Medicine > CEL-SCI Corporation

CEL-SCI Corporation
AMEX: CVM
Change
symbol:
     
 PROFILE
CEL-SCI is working on immunotherapy drugs for cancer patients and vaccines to prevent AIDS. The company's Multikine -- made through a proprietary cell-culture technique -- is being tested to treat head and neck cancer, prostate cancer, and HIV. CEL-SCI's T cell modulation technology, called LEAPS, may lead to synthetic vaccines for AIDS, prostate and breast cancer, and herpes. The firm halted development of its HGP-30 AIDS vaccine, which would have treated the form of HIV most prevalent in Africa. CEL-SCI collaborates with institutions like The Johns Hopkins University and Northeastern Ohio University to fund research and development of its products, all of which are in clinical tests in the US and other regions.

 COMPETITION
Chiron Corporation (CHIR)
Introgen Therapeutics, Inc. (INGN)
Progenics Pharmaceuticals, Inc. (PGNX)

 STOCK ANALYSIS
 View by:
 Day 
 Day 
 Month 
 Month 
 Year 
 Year 
FURTHER ANALYSIS
• Advanced Charting
• Deals

 FINANCIAL OVERVIEW
Fiscal Year-End: September
2000 Sales (mil.): 0.40
1-Yr. Sales Growth: 0.0%
Employees: 32
Revenue per employee: $12,500.00

 KEY PEOPLE
• Geert R. Kersten
    CEO
• Geert R. Kersten
    CFO

 CONTACT INFO
8229 Boone Blvd., Ste. 802
Vienna, VA 22182
US
Phone: 703-506-9460
Fax: 703-506-9471
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001